CLGN
CollPlant Biotechnologies LtdCompany with tickers: CLGN
CIK
1631487
CUSIP
M2R51X116
Shares Outstanding
14,423,253
13F Activity (30d)
15 filings
13 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 31,137 |
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 80,000 |
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel |
Director, Chief Executive Officer | Other | 0 |
| 2026-03-18 | Abelis Bar Berta |
VP Legal | Other | 40,000 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 0 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 0 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 0 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 12,000 |
| 2026-03-18 | Rotem Eran |
Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Lask Alisa |
Director | Other | 0 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 0 |
| 2026-03-18 | Rotem Eran |
Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 0 |
| 2026-03-18 | Abelis Bar Berta |
VP Legal | Other | 0 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 10,000 |
| 2026-03-18 | Penn Elan |
Director | Other | 0 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 10,000 |
| 2026-03-18 | Fahimipoor Oren |
VP Operations | Other | 30,000 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 2,000 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 315,554 |
| 2026-03-18 | Seror Jasmine |
VP Product Development | Other | 45,000 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 0 |
| 2026-03-18 | Rotem Eran |
Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Penn Elan |
Director | Other | 0 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 0 |
| 2026-03-18 | Penn Elan |
Director | Other | 0 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 0 |
| 2026-03-18 | Fahimipoor Oren |
VP Operations | Other | 0 |
| 2026-03-18 | Havron Avraham |
Director | Other | 10,000 |
| 2026-03-18 | Rotem Eran |
Deputy CEO and CFO | Other | 60,000 |
| 2026-03-18 | Havron Avraham |
Director | Other | 0 |
| 2026-03-18 | Abelis Bar Berta |
VP Legal | Other | 13,000 |
| 2026-03-18 | Evans Hugh M |
Director | Other | 15,000 |
| 2026-03-18 | Havron Avraham |
Director | Other | 0 |
| 2026-03-18 | Lask Alisa |
Director | Other | 10,000 |
| 2026-03-18 | Bensimon Philippe |
VP Regulations and QA | Other | 30,000 |
| 2026-03-18 | Bagley Bowman |
VP Commercial North America | Other | 25,000 |
| 2026-03-18 | Penn Elan |
Director | Other | 7,500 |
| 2026-03-18 | Havron Avraham |
Director | Other | 0 |
| 2026-03-18 | Rotem Eran |
Deputy CEO and CFO | Other | 0 |
Showing 1–46 of 46 transactions